UTZ vs. MED, FARM, JVA, TTCFQ, MKC, SCI, CHWY, COKE, COTY, and PPC
Should you be buying Utz Brands stock or one of its competitors? The main competitors of Utz Brands include Medifast (MED), Farmer Bros. (FARM), Coffee (JVA), Tattooed Chef (TTCFQ), McCormick & Company, Incorporated (MKC), Service Co. International (SCI), Chewy (CHWY), Coca-Cola Consolidated (COKE), Coty (COTY), and Pilgrim's Pride (PPC).
Medifast (NYSE:MED) and Utz Brands (NYSE:UTZ) are both consumer staples companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, community ranking, institutional ownership, analyst recommendations, risk, media sentiment, earnings and dividends.
Medifast has a net margin of 7.55% compared to Medifast's net margin of -1.38%. Utz Brands' return on equity of 36.64% beat Medifast's return on equity.
Medifast currently has a consensus target price of $53.50, indicating a potential upside of 107.85%. Utz Brands has a consensus target price of $20.42, indicating a potential upside of 10.12%. Given Utz Brands' higher possible upside, equities analysts plainly believe Medifast is more favorable than Utz Brands.
Medifast has higher earnings, but lower revenue than Utz Brands. Utz Brands is trading at a lower price-to-earnings ratio than Medifast, indicating that it is currently the more affordable of the two stocks.
95.5% of Medifast shares are held by institutional investors. Comparatively, 96.0% of Utz Brands shares are held by institutional investors. 2.5% of Medifast shares are held by company insiders. Comparatively, 17.0% of Utz Brands shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Medifast received 332 more outperform votes than Utz Brands when rated by MarketBeat users. Likewise, 63.94% of users gave Medifast an outperform vote while only 60.00% of users gave Utz Brands an outperform vote.
Medifast pays an annual dividend of $6.60 per share and has a dividend yield of 25.6%. Utz Brands pays an annual dividend of $0.24 per share and has a dividend yield of 1.3%. Medifast pays out 106.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Utz Brands pays out -96.0% of its earnings in the form of a dividend. Medifast has raised its dividend for 1 consecutive years and Utz Brands has raised its dividend for 3 consecutive years.
Medifast has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500. Comparatively, Utz Brands has a beta of 0.97, indicating that its stock price is 3% less volatile than the S&P 500.
In the previous week, Utz Brands had 4 more articles in the media than Medifast. MarketBeat recorded 5 mentions for Utz Brands and 1 mentions for Medifast. Medifast's average media sentiment score of 0.92 beat Utz Brands' score of 0.00 indicating that Utz Brands is being referred to more favorably in the news media.
Summary
Medifast beats Utz Brands on 11 of the 21 factors compared between the two stocks.
Get Utz Brands News Delivered to You Automatically
Sign up to receive the latest news and ratings for UTZ and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding UTZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Utz Brands Competitors List
Related Companies and Tools
